nodes	percent_of_prediction	percent_of_DWPC	metapath
Glycerol Phenylbutyrate—PNLIP—exocrine gland—uterine cancer	0.189	0.618	CbGeAlD
Glycerol Phenylbutyrate—PNLIP—Retinoid metabolism and transport—AKR1B10—uterine cancer	0.0963	0.182	CbGpPWpGaD
Glycerol Phenylbutyrate—PNLIP—Retinoid metabolism and transport—AKR1C1—uterine cancer	0.0657	0.124	CbGpPWpGaD
Glycerol Phenylbutyrate—PNLIP—female reproductive system—uterine cancer	0.0612	0.2	CbGeAlD
Glycerol Phenylbutyrate—PNLIP—female gonad—uterine cancer	0.0557	0.182	CbGeAlD
Glycerol Phenylbutyrate—PNLIP—Retinoid metabolism and transport—AKR1C3—uterine cancer	0.0506	0.0954	CbGpPWpGaD
Glycerol Phenylbutyrate—PNLIP—Diseases associated with visual transduction—AKR1B10—uterine cancer	0.0491	0.0927	CbGpPWpGaD
Glycerol Phenylbutyrate—PNLIP—Diseases associated with visual transduction—AKR1C1—uterine cancer	0.0335	0.0633	CbGpPWpGaD
Glycerol Phenylbutyrate—PNLIP—Diseases associated with visual transduction—AKR1C3—uterine cancer	0.0258	0.0487	CbGpPWpGaD
Glycerol Phenylbutyrate—PNLIP—Metabolism of lipids and lipoproteins—SRD5A2—uterine cancer	0.0151	0.0285	CbGpPWpGaD
Glycerol Phenylbutyrate—PNLIP—Metabolism of lipids and lipoproteins—AKR1B1—uterine cancer	0.0109	0.0206	CbGpPWpGaD
Glycerol Phenylbutyrate—PNLIP—Metabolism of lipids and lipoproteins—STAR—uterine cancer	0.0109	0.0206	CbGpPWpGaD
Glycerol Phenylbutyrate—PNLIP—Metabolism of lipids and lipoproteins—AKR1C1—uterine cancer	0.00801	0.0151	CbGpPWpGaD
Glycerol Phenylbutyrate—PNLIP—Metabolism—SRD5A2—uterine cancer	0.00672	0.0127	CbGpPWpGaD
Glycerol Phenylbutyrate—PNLIP—Metabolism—NDUFB11—uterine cancer	0.00672	0.0127	CbGpPWpGaD
Glycerol Phenylbutyrate—PNLIP—Metabolism of lipids and lipoproteins—CYP11A1—uterine cancer	0.00653	0.0123	CbGpPWpGaD
Glycerol Phenylbutyrate—PNLIP—Disease—AKR1B10—uterine cancer	0.00624	0.0118	CbGpPWpGaD
Glycerol Phenylbutyrate—PNLIP—Metabolism of lipids and lipoproteins—AKR1C3—uterine cancer	0.00617	0.0116	CbGpPWpGaD
Glycerol Phenylbutyrate—Abdominal discomfort—Progesterone—uterine cancer	0.00584	0.0356	CcSEcCtD
Glycerol Phenylbutyrate—Abdominal discomfort—Medroxyprogesterone Acetate—uterine cancer	0.0053	0.0323	CcSEcCtD
Glycerol Phenylbutyrate—PNLIP—Disease—RNF43—uterine cancer	0.00517	0.00976	CbGpPWpGaD
Glycerol Phenylbutyrate—PNLIP—Metabolism—AKR1B1—uterine cancer	0.00486	0.00917	CbGpPWpGaD
Glycerol Phenylbutyrate—PNLIP—Metabolism—STAR—uterine cancer	0.00486	0.00917	CbGpPWpGaD
Glycerol Phenylbutyrate—PNLIP—Metabolism of lipids and lipoproteins—CYP19A1—uterine cancer	0.0048	0.00907	CbGpPWpGaD
Glycerol Phenylbutyrate—PNLIP—Signaling Pathways—AKR1B10—uterine cancer	0.00437	0.00825	CbGpPWpGaD
Glycerol Phenylbutyrate—PNLIP—Disease—AKR1C1—uterine cancer	0.00426	0.00804	CbGpPWpGaD
Glycerol Phenylbutyrate—Malnutrition—Progesterone—uterine cancer	0.00425	0.0259	CcSEcCtD
Glycerol Phenylbutyrate—Flatulence—Progesterone—uterine cancer	0.00419	0.0255	CcSEcCtD
Glycerol Phenylbutyrate—Malnutrition—Medroxyprogesterone Acetate—uterine cancer	0.00385	0.0235	CcSEcCtD
Glycerol Phenylbutyrate—PNLIP—Metabolism—POLD1—uterine cancer	0.00381	0.0072	CbGpPWpGaD
Glycerol Phenylbutyrate—Flatulence—Medroxyprogesterone Acetate—uterine cancer	0.00379	0.0231	CcSEcCtD
Glycerol Phenylbutyrate—PNLIP—Disease—DCN—uterine cancer	0.00368	0.00695	CbGpPWpGaD
Glycerol Phenylbutyrate—PNLIP—Signaling Pathways—RNF43—uterine cancer	0.00362	0.00684	CbGpPWpGaD
Glycerol Phenylbutyrate—PNLIP—Metabolism—AKR1C1—uterine cancer	0.00357	0.00673	CbGpPWpGaD
Glycerol Phenylbutyrate—Nervous system disorder—Progesterone—uterine cancer	0.0034	0.0207	CcSEcCtD
Glycerol Phenylbutyrate—PNLIP—Signaling Pathways—INHBA—uterine cancer	0.00331	0.00625	CbGpPWpGaD
Glycerol Phenylbutyrate—PNLIP—Disease—AKR1C3—uterine cancer	0.00328	0.00619	CbGpPWpGaD
Glycerol Phenylbutyrate—PNLIP—Disease—HMGA1—uterine cancer	0.00319	0.00603	CbGpPWpGaD
Glycerol Phenylbutyrate—PNLIP—Metabolism—RRM2—uterine cancer	0.00318	0.006	CbGpPWpGaD
Glycerol Phenylbutyrate—PNLIP—Metabolism—DCN—uterine cancer	0.00309	0.00582	CbGpPWpGaD
Glycerol Phenylbutyrate—Nervous system disorder—Medroxyprogesterone Acetate—uterine cancer	0.00308	0.0188	CcSEcCtD
Glycerol Phenylbutyrate—Dyspepsia—Progesterone—uterine cancer	0.00305	0.0186	CcSEcCtD
Glycerol Phenylbutyrate—Decreased appetite—Progesterone—uterine cancer	0.00301	0.0184	CcSEcCtD
Glycerol Phenylbutyrate—Gastrointestinal disorder—Progesterone—uterine cancer	0.00299	0.0182	CcSEcCtD
Glycerol Phenylbutyrate—Fatigue—Progesterone—uterine cancer	0.00299	0.0182	CcSEcCtD
Glycerol Phenylbutyrate—PNLIP—Signaling Pathways—AKR1C1—uterine cancer	0.00298	0.00563	CbGpPWpGaD
Glycerol Phenylbutyrate—PNLIP—Disease—FBXW7—uterine cancer	0.00292	0.00552	CbGpPWpGaD
Glycerol Phenylbutyrate—PNLIP—Metabolism—CYP11A1—uterine cancer	0.00291	0.00549	CbGpPWpGaD
Glycerol Phenylbutyrate—Gastrointestinal pain—Progesterone—uterine cancer	0.00283	0.0173	CcSEcCtD
Glycerol Phenylbutyrate—Dyspepsia—Medroxyprogesterone Acetate—uterine cancer	0.00277	0.0169	CcSEcCtD
Glycerol Phenylbutyrate—PNLIP—Metabolism—AKR1C3—uterine cancer	0.00275	0.00518	CbGpPWpGaD
Glycerol Phenylbutyrate—Abdominal pain—Progesterone—uterine cancer	0.00274	0.0167	CcSEcCtD
Glycerol Phenylbutyrate—Decreased appetite—Medroxyprogesterone Acetate—uterine cancer	0.00273	0.0166	CcSEcCtD
Glycerol Phenylbutyrate—Gastrointestinal disorder—Medroxyprogesterone Acetate—uterine cancer	0.00271	0.0165	CcSEcCtD
Glycerol Phenylbutyrate—Fatigue—Medroxyprogesterone Acetate—uterine cancer	0.00271	0.0165	CcSEcCtD
Glycerol Phenylbutyrate—Gastrointestinal pain—Medroxyprogesterone Acetate—uterine cancer	0.00257	0.0157	CcSEcCtD
Glycerol Phenylbutyrate—Asthenia—Progesterone—uterine cancer	0.00249	0.0152	CcSEcCtD
Glycerol Phenylbutyrate—Abdominal pain—Medroxyprogesterone Acetate—uterine cancer	0.00248	0.0151	CcSEcCtD
Glycerol Phenylbutyrate—Diarrhoea—Progesterone—uterine cancer	0.00237	0.0145	CcSEcCtD
Glycerol Phenylbutyrate—PNLIP—Signaling Pathways—AKR1C3—uterine cancer	0.0023	0.00433	CbGpPWpGaD
Glycerol Phenylbutyrate—Dizziness—Progesterone—uterine cancer	0.00229	0.014	CcSEcCtD
Glycerol Phenylbutyrate—PNLIP—Disease—CDKN2B—uterine cancer	0.00229	0.00432	CbGpPWpGaD
Glycerol Phenylbutyrate—Asthenia—Medroxyprogesterone Acetate—uterine cancer	0.00225	0.0137	CcSEcCtD
Glycerol Phenylbutyrate—PNLIP—Signaling Pathways—PGR—uterine cancer	0.00224	0.00422	CbGpPWpGaD
Glycerol Phenylbutyrate—Vomiting—Progesterone—uterine cancer	0.0022	0.0134	CcSEcCtD
Glycerol Phenylbutyrate—Rash—Progesterone—uterine cancer	0.00219	0.0133	CcSEcCtD
Glycerol Phenylbutyrate—Dermatitis—Progesterone—uterine cancer	0.00218	0.0133	CcSEcCtD
Glycerol Phenylbutyrate—Headache—Progesterone—uterine cancer	0.00217	0.0132	CcSEcCtD
Glycerol Phenylbutyrate—Diarrhoea—Medroxyprogesterone Acetate—uterine cancer	0.00215	0.0131	CcSEcCtD
Glycerol Phenylbutyrate—PNLIP—Metabolism—STK11—uterine cancer	0.00214	0.00404	CbGpPWpGaD
Glycerol Phenylbutyrate—PNLIP—Metabolism—CYP19A1—uterine cancer	0.00214	0.00404	CbGpPWpGaD
Glycerol Phenylbutyrate—PNLIP—Signaling Pathways—YWHAE—uterine cancer	0.00213	0.00403	CbGpPWpGaD
Glycerol Phenylbutyrate—Decreased appetite—Dactinomycin—uterine cancer	0.00213	0.013	CcSEcCtD
Glycerol Phenylbutyrate—Fatigue—Dactinomycin—uterine cancer	0.00211	0.0129	CcSEcCtD
Glycerol Phenylbutyrate—PNLIP—Disease—SMAD3—uterine cancer	0.00209	0.00395	CbGpPWpGaD
Glycerol Phenylbutyrate—Dizziness—Medroxyprogesterone Acetate—uterine cancer	0.00208	0.0127	CcSEcCtD
Glycerol Phenylbutyrate—Nausea—Progesterone—uterine cancer	0.00206	0.0126	CcSEcCtD
Glycerol Phenylbutyrate—PNLIP—Signaling Pathways—FBXW7—uterine cancer	0.00205	0.00386	CbGpPWpGaD
Glycerol Phenylbutyrate—PNLIP—Metabolism of lipids and lipoproteins—PTEN—uterine cancer	0.00201	0.00379	CbGpPWpGaD
Glycerol Phenylbutyrate—Gastrointestinal pain—Dactinomycin—uterine cancer	0.002	0.0122	CcSEcCtD
Glycerol Phenylbutyrate—Vomiting—Medroxyprogesterone Acetate—uterine cancer	0.002	0.0122	CcSEcCtD
Glycerol Phenylbutyrate—PNLIP—Disease—FGFR2—uterine cancer	0.00199	0.00376	CbGpPWpGaD
Glycerol Phenylbutyrate—Rash—Medroxyprogesterone Acetate—uterine cancer	0.00198	0.0121	CcSEcCtD
Glycerol Phenylbutyrate—Dermatitis—Medroxyprogesterone Acetate—uterine cancer	0.00198	0.0121	CcSEcCtD
Glycerol Phenylbutyrate—Headache—Medroxyprogesterone Acetate—uterine cancer	0.00197	0.012	CcSEcCtD
Glycerol Phenylbutyrate—Abdominal pain—Dactinomycin—uterine cancer	0.00194	0.0118	CcSEcCtD
Glycerol Phenylbutyrate—PNLIP—Disease—MTHFR—uterine cancer	0.00192	0.00362	CbGpPWpGaD
Glycerol Phenylbutyrate—PNLIP—Metabolism of lipids and lipoproteins—EP300—uterine cancer	0.00191	0.00361	CbGpPWpGaD
Glycerol Phenylbutyrate—Nausea—Medroxyprogesterone Acetate—uterine cancer	0.00187	0.0114	CcSEcCtD
Glycerol Phenylbutyrate—Abdominal pain upper—Epirubicin—uterine cancer	0.00185	0.0113	CcSEcCtD
Glycerol Phenylbutyrate—PNLIP—Signaling Pathways—STK11—uterine cancer	0.00179	0.00338	CbGpPWpGaD
Glycerol Phenylbutyrate—Asthenia—Dactinomycin—uterine cancer	0.00176	0.0107	CcSEcCtD
Glycerol Phenylbutyrate—Abdominal pain upper—Doxorubicin—uterine cancer	0.00171	0.0104	CcSEcCtD
Glycerol Phenylbutyrate—Diarrhoea—Dactinomycin—uterine cancer	0.00168	0.0102	CcSEcCtD
Glycerol Phenylbutyrate—PNLIP—Signaling Pathways—SOCS3—uterine cancer	0.00167	0.00316	CbGpPWpGaD
Glycerol Phenylbutyrate—PNLIP—Metabolism—MTHFR—uterine cancer	0.00161	0.00303	CbGpPWpGaD
Glycerol Phenylbutyrate—PNLIP—Signaling Pathways—CDKN2B—uterine cancer	0.0016	0.00303	CbGpPWpGaD
Glycerol Phenylbutyrate—Vomiting—Dactinomycin—uterine cancer	0.00156	0.0095	CcSEcCtD
Glycerol Phenylbutyrate—PNLIP—Signaling Pathways—IGF1R—uterine cancer	0.00156	0.00294	CbGpPWpGaD
Glycerol Phenylbutyrate—Rash—Dactinomycin—uterine cancer	0.00154	0.00942	CcSEcCtD
Glycerol Phenylbutyrate—Decreased appetite—Etoposide—uterine cancer	0.00154	0.0094	CcSEcCtD
Glycerol Phenylbutyrate—Gastrointestinal disorder—Etoposide—uterine cancer	0.00153	0.00933	CcSEcCtD
Glycerol Phenylbutyrate—Fatigue—Etoposide—uterine cancer	0.00153	0.00932	CcSEcCtD
Glycerol Phenylbutyrate—PNLIP—Signaling Pathways—SMAD3—uterine cancer	0.00146	0.00276	CbGpPWpGaD
Glycerol Phenylbutyrate—Nausea—Dactinomycin—uterine cancer	0.00146	0.00887	CcSEcCtD
Glycerol Phenylbutyrate—Gastrointestinal pain—Etoposide—uterine cancer	0.00145	0.00884	CcSEcCtD
Glycerol Phenylbutyrate—PNLIP—Metabolism of lipids and lipoproteins—PIK3CA—uterine cancer	0.00142	0.00267	CbGpPWpGaD
Glycerol Phenylbutyrate—Abdominal pain—Etoposide—uterine cancer	0.0014	0.00854	CcSEcCtD
Glycerol Phenylbutyrate—PNLIP—Signaling Pathways—FGFR2—uterine cancer	0.0014	0.00264	CbGpPWpGaD
Glycerol Phenylbutyrate—Asthenia—Etoposide—uterine cancer	0.00127	0.00776	CcSEcCtD
Glycerol Phenylbutyrate—PNLIP—Disease—ERBB2—uterine cancer	0.00125	0.00236	CbGpPWpGaD
Glycerol Phenylbutyrate—Malnutrition—Epirubicin—uterine cancer	0.00122	0.00742	CcSEcCtD
Glycerol Phenylbutyrate—Diarrhoea—Etoposide—uterine cancer	0.00121	0.0074	CcSEcCtD
Glycerol Phenylbutyrate—Flatulence—Epirubicin—uterine cancer	0.0012	0.00732	CcSEcCtD
Glycerol Phenylbutyrate—PNLIP—Signaling Pathways—ESR1—uterine cancer	0.00119	0.00225	CbGpPWpGaD
Glycerol Phenylbutyrate—Dizziness—Etoposide—uterine cancer	0.00117	0.00715	CcSEcCtD
Glycerol Phenylbutyrate—PNLIP—Disease—CDKN1B—uterine cancer	0.00116	0.00219	CbGpPWpGaD
Glycerol Phenylbutyrate—Vomiting—Etoposide—uterine cancer	0.00113	0.00687	CcSEcCtD
Glycerol Phenylbutyrate—Malnutrition—Doxorubicin—uterine cancer	0.00113	0.00687	CcSEcCtD
Glycerol Phenylbutyrate—Rash—Etoposide—uterine cancer	0.00112	0.00682	CcSEcCtD
Glycerol Phenylbutyrate—Dermatitis—Etoposide—uterine cancer	0.00112	0.00681	CcSEcCtD
Glycerol Phenylbutyrate—Headache—Etoposide—uterine cancer	0.00111	0.00677	CcSEcCtD
Glycerol Phenylbutyrate—Flatulence—Doxorubicin—uterine cancer	0.00111	0.00677	CcSEcCtD
Glycerol Phenylbutyrate—PNLIP—Disease—CTNNB1—uterine cancer	0.0011	0.00207	CbGpPWpGaD
Glycerol Phenylbutyrate—PNLIP—Disease—PTEN—uterine cancer	0.00107	0.00202	CbGpPWpGaD
Glycerol Phenylbutyrate—Nausea—Etoposide—uterine cancer	0.00105	0.00642	CcSEcCtD
Glycerol Phenylbutyrate—PNLIP—Signaling Pathways—CCL2—uterine cancer	0.00105	0.00199	CbGpPWpGaD
Glycerol Phenylbutyrate—PNLIP—Disease—EP300—uterine cancer	0.00102	0.00192	CbGpPWpGaD
Glycerol Phenylbutyrate—Nervous system disorder—Epirubicin—uterine cancer	0.000975	0.00594	CcSEcCtD
Glycerol Phenylbutyrate—PNLIP—Disease—NRAS—uterine cancer	0.000953	0.0018	CbGpPWpGaD
Glycerol Phenylbutyrate—Nervous system disorder—Doxorubicin—uterine cancer	0.000902	0.0055	CcSEcCtD
Glycerol Phenylbutyrate—PNLIP—Metabolism—PTEN—uterine cancer	0.000894	0.00169	CbGpPWpGaD
Glycerol Phenylbutyrate—PNLIP—Signaling Pathways—ERBB2—uterine cancer	0.000877	0.00165	CbGpPWpGaD
Glycerol Phenylbutyrate—Dyspepsia—Epirubicin—uterine cancer	0.000875	0.00533	CcSEcCtD
Glycerol Phenylbutyrate—Decreased appetite—Epirubicin—uterine cancer	0.000864	0.00527	CcSEcCtD
Glycerol Phenylbutyrate—Gastrointestinal disorder—Epirubicin—uterine cancer	0.000858	0.00523	CcSEcCtD
Glycerol Phenylbutyrate—Fatigue—Epirubicin—uterine cancer	0.000857	0.00522	CcSEcCtD
Glycerol Phenylbutyrate—PNLIP—Metabolism—EP300—uterine cancer	0.000853	0.00161	CbGpPWpGaD
Glycerol Phenylbutyrate—PNLIP—Signaling Pathways—CXCL8—uterine cancer	0.000832	0.00157	CbGpPWpGaD
Glycerol Phenylbutyrate—PNLIP—Disease—KRAS—uterine cancer	0.00082	0.00155	CbGpPWpGaD
Glycerol Phenylbutyrate—Gastrointestinal pain—Epirubicin—uterine cancer	0.000813	0.00495	CcSEcCtD
Glycerol Phenylbutyrate—PNLIP—Signaling Pathways—CDKN1B—uterine cancer	0.000812	0.00153	CbGpPWpGaD
Glycerol Phenylbutyrate—Dyspepsia—Doxorubicin—uterine cancer	0.00081	0.00494	CcSEcCtD
Glycerol Phenylbutyrate—Decreased appetite—Doxorubicin—uterine cancer	0.0008	0.00487	CcSEcCtD
Glycerol Phenylbutyrate—Gastrointestinal disorder—Doxorubicin—uterine cancer	0.000794	0.00484	CcSEcCtD
Glycerol Phenylbutyrate—Fatigue—Doxorubicin—uterine cancer	0.000793	0.00483	CcSEcCtD
Glycerol Phenylbutyrate—Abdominal pain—Epirubicin—uterine cancer	0.000786	0.00479	CcSEcCtD
Glycerol Phenylbutyrate—PNLIP—Signaling Pathways—CTNNB1—uterine cancer	0.000767	0.00145	CbGpPWpGaD
Glycerol Phenylbutyrate—PNLIP—Disease—PIK3CA—uterine cancer	0.000753	0.00142	CbGpPWpGaD
Glycerol Phenylbutyrate—Gastrointestinal pain—Doxorubicin—uterine cancer	0.000752	0.00458	CcSEcCtD
Glycerol Phenylbutyrate—PNLIP—Signaling Pathways—PTEN—uterine cancer	0.000748	0.00141	CbGpPWpGaD
Glycerol Phenylbutyrate—Abdominal pain—Doxorubicin—uterine cancer	0.000727	0.00443	CcSEcCtD
Glycerol Phenylbutyrate—Asthenia—Epirubicin—uterine cancer	0.000713	0.00435	CcSEcCtD
Glycerol Phenylbutyrate—PNLIP—Signaling Pathways—EP300—uterine cancer	0.000713	0.00135	CbGpPWpGaD
Glycerol Phenylbutyrate—PNLIP—Disease—HRAS—uterine cancer	0.000697	0.00132	CbGpPWpGaD
Glycerol Phenylbutyrate—Diarrhoea—Epirubicin—uterine cancer	0.00068	0.00415	CcSEcCtD
Glycerol Phenylbutyrate—PNLIP—Signaling Pathways—VEGFA—uterine cancer	0.000675	0.00127	CbGpPWpGaD
Glycerol Phenylbutyrate—PNLIP—Signaling Pathways—NRAS—uterine cancer	0.000667	0.00126	CbGpPWpGaD
Glycerol Phenylbutyrate—Asthenia—Doxorubicin—uterine cancer	0.00066	0.00402	CcSEcCtD
Glycerol Phenylbutyrate—Dizziness—Epirubicin—uterine cancer	0.000657	0.00401	CcSEcCtD
Glycerol Phenylbutyrate—Vomiting—Epirubicin—uterine cancer	0.000632	0.00385	CcSEcCtD
Glycerol Phenylbutyrate—PNLIP—Metabolism—PIK3CA—uterine cancer	0.000631	0.00119	CbGpPWpGaD
Glycerol Phenylbutyrate—Diarrhoea—Doxorubicin—uterine cancer	0.000629	0.00384	CcSEcCtD
Glycerol Phenylbutyrate—Rash—Epirubicin—uterine cancer	0.000627	0.00382	CcSEcCtD
Glycerol Phenylbutyrate—Dermatitis—Epirubicin—uterine cancer	0.000626	0.00382	CcSEcCtD
Glycerol Phenylbutyrate—Headache—Epirubicin—uterine cancer	0.000623	0.0038	CcSEcCtD
Glycerol Phenylbutyrate—PNLIP—Disease—AKT1—uterine cancer	0.000615	0.00116	CbGpPWpGaD
Glycerol Phenylbutyrate—Dizziness—Doxorubicin—uterine cancer	0.000608	0.00371	CcSEcCtD
Glycerol Phenylbutyrate—Nausea—Epirubicin—uterine cancer	0.00059	0.0036	CcSEcCtD
Glycerol Phenylbutyrate—Vomiting—Doxorubicin—uterine cancer	0.000585	0.00356	CcSEcCtD
Glycerol Phenylbutyrate—Rash—Doxorubicin—uterine cancer	0.00058	0.00353	CcSEcCtD
Glycerol Phenylbutyrate—Dermatitis—Doxorubicin—uterine cancer	0.000579	0.00353	CcSEcCtD
Glycerol Phenylbutyrate—Headache—Doxorubicin—uterine cancer	0.000576	0.00351	CcSEcCtD
Glycerol Phenylbutyrate—PNLIP—Signaling Pathways—KRAS—uterine cancer	0.000574	0.00108	CbGpPWpGaD
Glycerol Phenylbutyrate—Nausea—Doxorubicin—uterine cancer	0.000546	0.00333	CcSEcCtD
Glycerol Phenylbutyrate—PNLIP—Signaling Pathways—PIK3CA—uterine cancer	0.000527	0.000996	CbGpPWpGaD
Glycerol Phenylbutyrate—PNLIP—Metabolism—AKT1—uterine cancer	0.000515	0.000973	CbGpPWpGaD
Glycerol Phenylbutyrate—PNLIP—Signaling Pathways—TP53—uterine cancer	0.00051	0.000963	CbGpPWpGaD
Glycerol Phenylbutyrate—PNLIP—Signaling Pathways—HRAS—uterine cancer	0.000488	0.000921	CbGpPWpGaD
Glycerol Phenylbutyrate—PNLIP—Signaling Pathways—AKT1—uterine cancer	0.000431	0.000813	CbGpPWpGaD
